These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24124355)

  • 1. Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients.
    Scichilone N; Battaglia S; Benfante A; Bellia V
    Clin Interv Aging; 2013; 8():1329-37. PubMed ID: 24124355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
    Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
    Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
    Bateman ED; Goehring UM; Richard F; Watz H
    J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Churg-Strauss syndrome in an asthmatic man treated with montelukast: continued controversy].
    Pérez de Llano LA; Veres Racamonde A; Parra Arrondo A
    Arch Bronconeumol; 2002 May; 38(5):251. PubMed ID: 12028935
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute Churg-Strauss syndrome in an asthmatic patient receiving montelukast therapy.
    Tang MB; Yosipovitch G
    Arch Dermatol; 2003 Jun; 139(6):715-8. PubMed ID: 12810501
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukotriene antagonists--do they have a value?].
    Stey C
    Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of montelukast.
    Price D
    Drugs; 2000; 59 Suppl 1():35-42; discussion 43-5. PubMed ID: 10741881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
    Wechsler ME; Pauwels R; Drazen JM
    Drug Saf; 1999 Oct; 21(4):241-51. PubMed ID: 10514017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
    Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
    Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast: data from clinical trials in the management of asthma.
    Blake KV
    Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.